// App-Quantinova.ai

S114 : PONATINIB AND BLINATUMOMAB FOR PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE II STUDY

Researchers

Presenter

  • Nicholas Short

Principal Investigators

  • Marina Konopleva

  • Nitin Jain

  • Farhad Ravandi

  • Xuelin Huang

  • Walid Macaron

  • William Wierda

  • Gautam Borthakur

  • Tapan Kadia

  • Koji Sasaki

  • Ghayas Issa

  • Guillermo Montalban-Bravo

  • Yesid Alvarado

  • Guillermo Garcia-Manero

  • Courtney Dinardo

  • Jennifer Thankachan

  • Ricardo Delumpa

  • Anna Milton

  • Juan Rivera

  • Christopher Loiselle

  • Rebecca Garris

  • Elias Jabbour

Medical Centers

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Leukem

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Department of Leukemia,University of Texas MD Anderson Cancer Center,Houston,Vereinigte Staaten

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Leukemia, The University of Texas MD Anderson Cancer Center,...

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

  • Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Aspartate aminotransferase

  • Alanine transaminase

  • Breakpoint Cluster Region

Drug/Treatment

  • Blinatumomab

  • Methotrexate

  • Cytarabine liposomal

  • Ponatinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved